| Biochemistry
| [0082]
|
| Anti-VEGF treatment in neovascular age-related macular degeneration: a treat-and-extend protocol over 2 years
| [0136]
|
| Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies.
| [0137]
|
| A2E induces IL-Iβ production in retinal pigment epithelial cells via the NLRP3 inflammasome
| [0137]
|
| Regression of atherosclerosis
| [0137]
|
| rAAV2/5 gene-targeting to rods: dose-dependent efficiency and complications associated with different promoters
| [0137]
|
| A survey of host range genes in poxvirus genomes
| [0137]
|
| Aβ-induced senescent retinal pigment epithelial cells create a proinflammatory microenvironment in AMD
| [0137]
|
| Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice
| [0137]
|
| Serum cytokine profile in adalimumab-treated refractory uveitis patients: decreased IL-22 correlates with clinical responses
| [0137]
|
| Diagnosis and Treatment of Uveitis
| [0137]
|
| Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS
| [0137]
|
| Treatment of Leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial
| [0137]
|
| A hapten generated from an oxidation fragment of docosahexaenoic acid is sufficient to initiate age-related macular degeneration
| [0137]
|
| Mechanisms of immune privilege in the anterior segment of the eye: what we learn from corneal transplantation
| [0137]
|
| Safety of recombinant adeno-associated virus type 2-RPE65 vector delivered by ocular subretinal injection
| [0137]
|
| A poxvirus-encoded pyrin domain protein interacts with ASC-1 to inhibit host inflammatory and apoptotic responses to infection
| [0137]
|
| Dynamic regulation of Ero1α and peroxiredoxin 4 localization in the secretory pathway
| [0137]
|
| Oxidative stress activates NLRP3 inflammasomes in ARPE-19 cells-implications for age-related macular degeneration (AMD)
| [0137]
|
| Targeting photoreceptors via intravitreal delivery using novel, capsid-mutated AAV vectors
| [0137]
|
| Myxomatosis in Australia and Europe: a model for emerging infectious diseases
| [0137]
|
| TLR-independent and P2X7-dependent signaling mediate Alu RNA-induced NLRP3 inflammasome activation in geographic atrophy
| [0137]
|
| Photoreceptor proteins initiate microglial activation via Toll-like receptor 4 in retinal degeneration mediated by all-trans-retinal
| [0137]
|
| Cleavage of structural proteins during the assembly of the head of bacteriophage T4
| [0137]
|
| The immunoregulatory properties of oncolytic myxoma virus and their implications in therapeutics
| [0137]
|
| The role of inflammasome in Alzheimer's disease
| [0137]
|
| Inflammatory mediators induced by amyloid-β in the retina and RPE in vivo: implications for inflammasome activation in age-related macular degeneration
| [0137]
|
| Secreted immunomodulatory viral proteins as novel biotherapeutics
| [0137]
|
| Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial
| [0137]
|
| Safety and efficacy of gene transfer for Leber's congenital amaurosis
| [0137]
|
| Immunological homeostasis of the eye
| [0137]
|
| Differential roles of AMPKα1 and AMPKα2 in regulating 4-HNE-induced RPE cell death and permeability
| [0137]
|
| Myxoma virus lacking the pyrin-like protein M013 is sensed in human myeloid cells by both NLRP3 and multiple Toll-like receptors, which independently activate the inflammasome and NF-κB innate response pathways
| [0137]
|
| Co-regulation of NF-κB and inflammasome-mediated inflammatory responses by myxoma virus pyrin domain-containing protein M013
| [0137]
|
| Myxoma virus protein M029 is a dual-function immunomodulator that inhibits PKR and also conscripts RHA/DHX9 to promote expanded host tropism and viral replication
| [0137]
|
| The Ca2+/H+ antiporter TMEM165 expression, localization in the developing, lactating and involuting mammary gland parallels the secretory pathway Ca2+ ATPase (SPCA1)
| [0137]
|
| Innate immune signals in autoimmune and autoinflammatory uveitis
| [0137]
|
| Endotoxin-induced uveitis in rats as a model for human disease
| [0137]
|
| Pathological consequences of long-term mitochondrial oxidative stress in the mouse retinal pigment epithelium
| [0137]
|
| Cytokine gene expression in different strains of mice with endotoxin-induced uveitis (EIU)
| [0137]
|
| A filtrable virus causing a tumor-like condition in rabbits and its relationship to virus myxomatosum
| [0137]
|
| Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administration
| [0137]
|
| J. Vis. Exp.
| [0137]
|
| Vaccinia virus immune evasion: mechanisms, virulence and immunogenicity
| [0137]
|
| Intracellular trafficking and secretion of inflammatory cytokines
| [0137]
|
| DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88
| [0137]
|
| Three-year follow-up after unilateral subretinal delivery of adeno-associated virus in patients with Leber congenital amaurosis type 2
| [0137]
|
| NLRP3 inflammasome activation in retinal pigment epithelial cells by lysosomal destabilization: implications for age-related macular degeneration
| [0137]
|
| Intraocular and serum cytokine profiles in patients with intermediate uveitis
| [0137]
|
| ACE2 and Ang-(1-7) confer protection against development of diabetic retinopathy
| [0137]
|
| Injury-induced upregulation of bFGF and CNTF mRNAS in the rat retina
| [0137]
|
| Current concepts in the pathogenesis of age-related macular degeneration
| [0137]
|
| Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors
| [0137]
|